Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to $5.9 million.

  • Milestone Scientific's Total Liabilities rose 5016.38% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 5016.38%. This contributed to the annual value of $4.0 million for FY2024, which is 1802.24% up from last year.
  • Per Milestone Scientific's latest filing, its Total Liabilities stood at $5.9 million for Q3 2025, which was up 5016.38% from $4.7 million recorded in Q2 2025.
  • Milestone Scientific's 5-year Total Liabilities high stood at $5.9 million for Q3 2025, and its period low was $3.0 million during Q1 2023.
  • For the 5-year period, Milestone Scientific's Total Liabilities averaged around $4.0 million, with its median value being $3.9 million (2024).
  • In the last 5 years, Milestone Scientific's Total Liabilities tumbled by 3877.89% in 2021 and then soared by 5016.38% in 2025.
  • Over the past 5 years, Milestone Scientific's Total Liabilities (Quarter) stood at $3.6 million in 2021, then increased by 2.82% to $3.7 million in 2022, then dropped by 9.11% to $3.4 million in 2023, then increased by 18.02% to $4.0 million in 2024, then soared by 49.75% to $5.9 million in 2025.
  • Its Total Liabilities stands at $5.9 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.6 million for Q1 2025.